— Know what they know.
Not Investment Advice

NERV NASDAQ

Minerva Neurosciences, Inc.
1W: -3.5% 1M: -26.8% 3M: -33.3% YTD: -16.3% 1Y: +56.2% 3Y: -55.1% 5Y: -79.9%
$3.28
+0.05 (+1.55%)
 
Weekly Expected Move ±8.2%
$3 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $152.8M mcap · 38M float · 0.586% daily turnover · Short 59% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-394M
Net Income
-5943.0% YoY
$-18,779M
Free Cash Flow
-121068.9% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE337.5%
ROA-628.4%
ROIC10.0%

Valuation

P/E-0.1
P/B-0.8
EV/EBITDA-0.9

Leverage

Debt/Equity0.00
Current Ratio20.14
Interest Cov.0.0x

Quality Scores

Piotroski F1/9
Altman Z-23.57
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms